Who invested in Faraday Pharmaceuticals?
Faraday Pharmaceuticals's investors include ARCH Venture Partners, Polaris Partners, Osage University Partners and Goldbell Group.

United States · Series C startup
Funding summaryUpdated 26 Oct 2026
$78Mraised across 3 rounds since 2014, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $53M sold, first sale Oct 2022
Reported by GeekWireSEC filing: $25M sold, first sale Aug 2019
From a historical funding recordSEC filing: $3.7M sold, first sale Jul 2014
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Faraday Pharmaceuticals's investors include ARCH Venture Partners, Polaris Partners, Osage University Partners and Goldbell Group.
Faraday Pharmaceuticals has raised $78M across 3 rounds since 2014. One round did not disclose an amount, so the total is a floor.
Faraday Pharmaceuticals's most recent round was a Series C of $53M in Nov 2022.
Its most recent round, $53M in Nov 2022, is also its largest on record.
Faraday Pharmaceuticals's first round on record, in Jul 2014, was backed by Osage University Partners.
Faraday Pharmaceuticals's latest named round is a Series C, in Nov 2022.
Faraday Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.